Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.

Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) conducted a revision of the 2009 guidelines by updating the evidence and recommendations. The scope of the 2016 guidelines remains the management of major depressive disorder (MDD) in adults, with a target audience of psychiatrists and other mental health professionals. Methods: Using the question-answer format, we conducted a systematic literature search focusing on systematic reviews and meta-analyses. Evidence was graded using CANMAT-defined criteria for level of evidence. Recommendations for lines of treatment were based on the quality of evidence and clinical expert consensus. “Complementary and Alternative Medicine Treatments” is the fifth of six sections of the 2016 guidelines. Results: Evidence-informed responses were developed for 12 questions for 2 broad categories of complementary and alternative medicine (CAM) interventions: 1) physical and meditative treatments (light therapy, sleep deprivation, exercise, yoga, and acupuncture) and 2) natural health products (St. John’s wort, omega-3 fatty acids; S-adenosyl-L-methionine [SAM-e], dehydroepiandrosterone, folate, Crocus sativus, and others). Recommendations were based on available data on efficacy, tolerability, and safety. Conclusions: For MDD of mild to moderate severity, exercise, light therapy, St. John’s wort, omega-3 fatty acids, SAM-e, and yoga are recommended as first- or second-line treatments. Adjunctive exercise and adjunctive St. John’s wort are second-line recommendations for moderate to severe MDD. Other physical treatments and natural health products have less evidence but may be considered as third-line treatments. CAM treatments are generally well tolerated. Caveats include methodological limitations of studies and paucity of data on long-term outcomes and drug interactions.

[1]  Elizabeth D Dalton,et al.  Second-tier natural antidepressants: review and critique. , 2011, Journal of affective disorders.

[2]  D. Carpenter St. John's wort and S-adenosyl methionine as "natural" alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit? , 2011, Alternative medicine review : a journal of clinical therapeutic.

[3]  L. Ginsberg,et al.  L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode. , 2011, Innovations in clinical neuroscience.

[4]  Omega-3 fatty acids and mood disorders. , 2006, The American journal of psychiatry.

[5]  S. Anton,et al.  A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes. , 2015, Journal of integrative medicine.

[6]  F. Benedetti,et al.  Sleep deprivation therapy for depression. , 2015, Current topics in behavioral neurosciences.

[7]  A. Panossian,et al.  Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR‐5 extract with warfarin and theophylline in rats , 2009, Phytotherapy research : PTR.

[8]  Jerson Laks,et al.  Physical Exercise and Clinically Depressed Patients: A Systematic Review and Meta-Analysis , 2013, Neuropsychobiology.

[9]  D. Kavanagh,et al.  Kava and St. John's Wort: current evidence for use in mood and anxiety disorders. , 2009, Journal of alternative and complementary medicine.

[10]  Joel Jeffries,et al.  Clinical Handbook of Psychotropic Drugs , 1994 .

[11]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[12]  L. Flicker,et al.  Systematic review and meta-analysis of randomized placebo-controlled trials of folate and vitamin B12 for depression , 2015, International Psychogeriatrics.

[13]  Y. Osher,et al.  Clinical trials of PUFAs in depression: State of the art , 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[14]  P. Bech,et al.  A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine. , 2012, The Journal of clinical psychiatry.

[15]  B. Crabtree,et al.  ’They Don’t Ask Me So I Don’t Tell Them’: Patient-Clinician Communication About Traditional, Complementary, and Alternative Medicine , 2009, The Annals of Family Medicine.

[16]  D. Kavanagh,et al.  Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. , 2009, Journal of psychiatric research.

[17]  P. Boyce,et al.  Manipulating melatonin in managing mood , 2013, Acta psychiatrica Scandinavica. Supplementum.

[18]  P. Masand,et al.  A review of current evidence for acetyl-l-carnitine in the treatment of depression. , 2014, Journal of psychiatric research.

[19]  Zhang-Jin Zhang,et al.  The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. , 2010, Journal of affective disorders.

[20]  S. Anton,et al.  Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. , 2013, Journal of integrative medicine.

[21]  J. Amsterdam,et al.  Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[22]  S. Patten,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. , 2009, Journal of affective disorders.

[23]  Rhian Gabe,et al.  Acupuncture and Counselling for Depression in Primary Care: A Randomised Controlled Trial , 2013, PLoS medicine.

[24]  P Bech,et al.  Maintained superiority of chronotherapeutics vs. exercise in a 20‐week randomized follow‐up trial in major depression , 2015, Acta psychiatrica Scandinavica.

[25]  H. Murck,et al.  St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial. , 2010, Journal of psychiatric research.

[26]  V. Butterweck,et al.  The mechanisms of action of St. John’s wort: an update , 2015, Wiener Medizinische Wochenschrift.

[27]  N. Iwata,et al.  A meta‐analysis of inositol for depression and anxiety disorders , 2014, Human psychopharmacology.

[28]  E. Ernst,et al.  An investigation of the contents of complementary and alternative medicine journals. , 2007, Alternative therapies in health and medicine.

[29]  L. Thabane,et al.  Light therapy for non-seasonal depression: systematic review and meta-analysis , 2016, BJPsych Open.

[30]  M. Bloch,et al.  Omega-3 Fatty Acids for the Treatment of Depression: Systematic Review and Meta-Analysis , 2011, Molecular Psychiatry.

[31]  Isabelle Boutron,et al.  Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. , 2004, Journal of clinical epidemiology.

[32]  Jon Adams,et al.  The use of complementary and alternative medicine in adults with depressive disorders. A critical integrative review. , 2015, Journal of affective disorders.

[33]  F. Benedetti,et al.  Chronobiological Therapy for Mood Disorders , 2015, Current Psychiatry Reports.

[34]  J. Richardson,et al.  Yoga for depression: the research evidence. , 2005, Journal of affective disorders.

[35]  Dietmar Winkler,et al.  Bright-Light Therapy in the Treatment of Mood Disorders , 2011, Neuropsychobiology.

[36]  D. Mischoulon,et al.  St John’s Wort (Hypericum perforatum) versus Sertraline and Placebo in Major Depressive Disorder: Continuation Data from a 26-Week RCT , 2012, Pharmacopsychiatry.

[37]  J. Lake,et al.  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. , 2006, The Journal of clinical psychiatry.

[38]  N. Kostomitsopoulos,et al.  Saffron: a natural product with potential pharmaceutical applications , 2015, The Journal of pharmacy and pharmacology.

[39]  Junmei Wu,et al.  Acupuncture for Depression: A Review of Clinical Applications , 2012, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[40]  J. Lake,et al.  Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. , 2010, The Journal of clinical psychiatry.

[41]  Roger B. Davis,et al.  Trends in use of complementary and alternative medicine by US adults: 1997-2002. , 2005, Alternative therapies in health and medicine.

[42]  Minakshi Sharma,et al.  Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode. , 2013, Asian journal of psychiatry.

[43]  P. Reaburn,et al.  Exercise and the treatment of depression: a review of the exercise program variables. , 2014, Journal of science and medicine in sport.

[44]  N. Parvin,et al.  The Effects of Lavandula Angustifolia Mill Infusion on Depression in Patients Using Citalopram: A comparison Study , 2013, Iranian Red Crescent medical journal.

[45]  Fei Liu,et al.  Clinical significance of decreased protein expression of dehydroepiandrosterone sulfate in the development of depression: a meta-analysis. , 2015, Journal of affective disorders.

[46]  M. Waern,et al.  Exercise in the treatment of major depression: A systematic review grading the quality of evidence , 2013, Physiotherapy theory and practice.

[47]  R. Lam,et al.  Update on the Biology of Seasonal Affective Disorder , 2005, CNS Spectrums.

[48]  R. Lam,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder , 2016, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[49]  G. Martinotti,et al.  A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder. , 2016, CNS & neurological disorders drug targets.

[50]  S. Kennedy,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. , 2006, Bipolar disorders.

[51]  J. Loftis,et al.  Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. , 2006, Pharmacology & therapeutics.

[52]  A. Tiedemann,et al.  Physical activity interventions for people with mental illness: a systematic review and meta-analysis. , 2014, The Journal of clinical psychiatry.

[53]  A. Ravindran,et al.  Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review. , 2013, Journal of affective disorders.

[54]  Amanda T. Woodward,et al.  Use of complementary and alternative medicines for mental and substance use disorders: A comparison of African Americans, black Caribbeans, and non-Hispanic whites , 2009 .

[55]  P. Drummond,et al.  Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action , 2014, Human psychopharmacology.

[56]  J. Langhorst,et al.  YOGA FOR DEPRESSION: A SYSTEMATIC REVIEW AND META‐ANALYSIS , 2013, Depression and anxiety.

[57]  P. Carlbring,et al.  Treating Major Depression with Physical Activity: A Systematic Overview with Recommendations , 2015, Cognitive behaviour therapy.

[58]  T. Archer,et al.  Physical exercise intervention in depressive disorders: Meta‐analysis and systematic review , 2014, Scandinavian journal of medicine & science in sports.

[59]  P. Hay,et al.  Acupuncture for depression. , 2005, The Cochrane database of systematic reviews.

[60]  S. Nikfar,et al.  Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: A meta-analysis , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[61]  Suzanne B DeBow,et al.  Bmc Complementary and Alternative Medicine a Systematic Review of How Homeopathy Is Represented in Conventional and Cam Peer Reviewed Journals , 2005 .

[62]  A. Nardi,et al.  What is the effectiveness of the use of polyunsaturated fatty acid omega-3 in the treatment of depression? , 2010, Expert review of neurotherapeutics.

[63]  J. Alpert,et al.  Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder , 2012, European Psychiatry.

[64]  P. Bech,et al.  The Day-to-Day Acute Effect of Wake Therapy in Patients with Major Depression Using the HAM-D6 as Primary Outcome Measure: Results from a Randomised Controlled Trial , 2013, PloS one.

[65]  N. A. Qureshi,et al.  Mood disorders and complementary and alternative medicine: a literature review , 2013, Neuropsychiatric disease and treatment.

[66]  A. Scholey,et al.  Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence , 2011, European Neuropsychopharmacology.

[67]  G. Faulkner,et al.  Physical activity and the prevention of depression: a systematic review of prospective studies. , 2013, American journal of preventive medicine.

[68]  D. Carpenter John ’ s Wort and S-Adenosyl Methionine as “ Natural ” Alternatives to Conventional Antidepressants in the Era of the Suicidality Boxed Warning : What is the Evidence for Clinically Relevant Bene ! t ? , 2022 .

[69]  M. George,et al.  Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study. , 2014, Journal of psychiatric research.

[70]  P. Gerbarg,et al.  Sudarshan Kriya yogic breathing in the treatment of stress, anxiety, and depression: part I-neurophysiologic model. , 2005, Journal of alternative and complementary medicine.

[71]  V. Montori,et al.  A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. , 2009, The Journal of clinical endocrinology and metabolism.

[72]  S. Patten,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. , 2009, Journal of affective disorders.

[73]  M. Fava,et al.  S-adenosyl-methionine in depression: A comprehensive review of the literature , 2003, Current psychiatry reports.

[74]  J. Mann,et al.  Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. , 2011, The Journal of clinical psychiatry.

[75]  P. Vacek,et al.  Randomized Trial of Cognitive-Behavioral Therapy Versus Light Therapy for Seasonal Affective Disorder: Acute Outcomes. , 2015, The American journal of psychiatry.

[76]  G. Papakostas,et al.  Folates and S-Adenosylmethionine for Major Depressive Disorder , 2012, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[77]  Masahiro Takeshima,et al.  Total sleep deprivation followed by sleep phase advance and bright light therapy in drug-resistant mood disorders. , 2013, Journal of affective disorders.

[78]  S. Wisniewski,et al.  The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. , 2011, The Journal of clinical psychiatry.

[79]  P. Vacek,et al.  Outcomes One and Two Winters Following Cognitive-Behavioral Therapy or Light Therapy for Seasonal Affective Disorder. , 2016, The American journal of psychiatry.

[80]  J. Hawrelak,et al.  Herbal medicines, other than St. John's Wort, in the treatment of depression: a systematic review. , 2011, Alternative medicine review : a journal of clinical therapeutic.

[81]  Neuropsychiatric Symptoms and the Use of Complementary and Alternative Medicine , 2013, PM & R : the journal of injury, function, and rehabilitation.

[82]  Amanda T. Woodward,et al.  Complementary and alternative medicine for mental disorders among African Americans, black Caribbeans, and whites. , 2009, Psychiatric services.

[83]  Are Tryptophan and 5-Hydroxytryptophan Effective Treatments for Depression? A Meta-Analysis∗ , 2002, The Australian and New Zealand journal of psychiatry.

[84]  D. Lawlor,et al.  The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. , 2011, The Journal of clinical psychiatry.

[85]  W. Bunney,et al.  Rapid-acting antidepressant strategies: mechanisms of action. , 2012, The international journal of neuropsychopharmacology.

[86]  Hsiao-Yun Chang,et al.  Exploring the decision to disclose the use of natural products among outpatients: a mixed-method study , 2013, BMC Complementary and Alternative Medicine.

[87]  Anxiety Treatments Clinical guidelines for the treatment of depressive disorders. , 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[88]  L. Berglund,et al.  Bright white light therapy in depression: A critical review of the evidence. , 2015, Journal of affective disorders.

[89]  Raymond W Lam,et al.  Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial. , 2016, JAMA psychiatry.

[90]  Jaung-Geng Lin,et al.  The benefit of combined acupuncture and antidepressant medication for depression: A systematic review and meta-analysis. , 2015, Journal of affective disorders.

[91]  J. Crawford,et al.  Laser acupuncture for depression: a randomised double blind controlled trial using low intensity laser intervention. , 2013, Journal of affective disorders.

[92]  M. Kotler,et al.  A multistage chronobiologic intervention for the treatment of depression: a pilot study. , 2009, Journal of affective disorders.

[93]  G. Grosso,et al.  Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials , 2014, PloS one.

[94]  D. Vancampfort,et al.  Dropout from exercise randomized controlled trials among people with depression: A meta-analysis and meta regression. , 2016, Journal of affective disorders.

[95]  K. Bone,et al.  The Essential Guide to Herbal Safety , 2005 .

[96]  M. Fava,et al.  Folate in depression: efficacy, safety, differences in formulations, and clinical issues. , 2010, The Journal of clinical psychiatry.

[97]  Kerry Dwan,et al.  Exercise for depression , 2014 .

[98]  A. Brattström Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression. , 2009, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[99]  F. Borrelli,et al.  Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations , 2009, The AAPS Journal.

[100]  H. Möller,et al.  Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression , 2010, International clinical psychopharmacology.

[101]  P. Reaburn,et al.  Is Cardiovascular or Resistance Exercise Better to Treat Patients With Depression? A Narrative Review , 2013, Issues in Mental Health Nursing.

[102]  Rachel Churchill,et al.  Omega-3 fatty acids for depression in adults. , 2015, The Cochrane database of systematic reviews.